Clincosm LogoSign in Get a demo

covid-19

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in United States (Vaccine Messaging, Vaccine Acceptance Question)

Not yet recruiting
  • COVID-19
  • Vaccine Messaging
  • Vaccine Acceptance Question
  • San Francisco, California
  • +6 more
Dec 1, 2023

COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

Not yet recruiting
  • COVID-19
  • XBB.1.5 Vaccine (Booster)
  • XBB.1.5 Vaccine (single dose)
  • Mobile, Alabama
  • +29 more
Aug 4, 2023

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

COVID-19 Trial in Philadelphia (COVID Booster text messages)

Enrolling by invitation
  • COVID-19
  • COVID Booster text messages
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 3, 2023

COVID-19 Trial in Philadelphia (COVID Booster text messages)

Enrolling by invitation
  • COVID-19
  • COVID Booster text messages
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 3, 2023

COVID-19 Trial in Philadelphia (COVID Booster text messages)

Enrolling by invitation
  • COVID-19
  • COVID Booster text messages
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 3, 2023

COVID-19 Trial in Philadelphia (COVID Booster text messages)

Enrolling by invitation
  • COVID-19
  • COVID Booster text messages
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 3, 2023

COVID-19 Trial in Philadelphia (COVID Booster text messages)

Enrolling by invitation
  • COVID-19
  • COVID Booster text messages
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 3, 2023

COVID-19 Trial in United States (Hemopurifier)

Terminated
  • COVID-19
  • Hemopurifier
  • Irvine, California
  • +8 more
Dec 16, 2022

Covid-19 Trial in Worldwide (CPI-006 2 mg/kg + SOC, CPI-006 1 mg/kg + SOC, Placebo + SOC)

Terminated
Has Results
  • Covid-19
  • CPI-006 2 mg/kg + SOC
  • +2 more
  • Chula Vista, California
  • +90 more
Sep 7, 2022

COVID Booster in Pregnancy and Lactation

Recruiting
  • COVID-19
  • Bivalent COVID-19 Booster
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Sep 14, 2022

COVID-19 Trial in Worldwide (SARS-CoV-2 mRNA vaccine formulation 1, SARS-CoV-2 mRNA vaccine formulation 2, SARS-CoV-2 mRNA

Terminated
  • COVID-19
  • SARS-CoV-2 mRNA vaccine formulation 1
  • +3 more
  • Rolling Hills Estates, California
  • +20 more
Aug 22, 2022

COVID-19 Trial in Worldwide (Remdesivir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +36 more
Aug 18, 2022

COVID-19 Trial in Philadelphia (Mouth rinse)

Completed
  • COVID-19
  • Mouth rinse
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 21, 2022

COVID-19 Trial in Argentina, Puerto Rico, United States (Bamlanivimab, Etesevimab, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +140 more
Jun 7, 2022

COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +71 more
Jun 22, 2022

Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)

Recruiting
  • Lower Respiratory Tract Infection
  • +3 more
  • Duarte, California
  • +59 more
Jun 3, 2022

COVID-19 Trial in Worldwide (Remdesivir, RDV Placebo, Standard of Care)

Terminated
  • COVID-19
  • Birmingham, Alabama
  • +62 more
Jun 1, 2022

Covid-19 Trial in Philadelphia (COVID-19 Convalescent Plasma)

Completed
Has Results
  • Covid-19
  • COVID-19 Convalescent Plasma
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Mar 31, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +59 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Interferon beta-1a, Placebo, Remdesivir)

Completed
Has Results
  • COVID-19
  • Interferon beta-1a
  • +2 more
  • Birmingham, Alabama
  • +63 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

Completed
Has Results
  • COVID-19
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +70 more
Mar 9, 2022

COVID-19 Trial in Canada, United States (Dapsone 85 mg PO BID, Placebo 85 mg PO BID)

Recruiting
  • COVID-19
  • Dapsone 85 mg PO BID
  • Placebo 85 mg PO BID
  • Phoenix, Arizona
  • +6 more
Feb 22, 2022

COVID-19 Trial in United States (Brequinar, Standard of Care)

Completed
Has Results
  • COVID-19
  • Hartford, Connecticut
  • +4 more
Feb 15, 2022